Placeholder Banner

New Study: 340B Entities Not Using the Program as Intended

June 9, 2015
A new analysis released by Avalere Health and funded by the Alliance for Integrity and Reform of 340B (AIR 340B) found hospitals participating in the 340B drug pricing program were more likely to acquire independent physician practices than non-340B hospitals. This study looks beyond past research on hospital acquisitions, which largely focused on the higher costs associated with the acquisition of physician practices, to the likelihood of acquisitions among 340B and non-340B entities.

This research provides further evidence that some 340B entities are not using the program as intended, and, as a result, health care costs are rising. Following are some tweets that highlight key findings and statistics around the new report.

[Note: BIO is a member of the AIR 340B Coalition.]

The full study is available here. The AIR 340B press release is available here.